Health/Biotech
-
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Second Consecutive Year
-
Manhattan Pharmaceuticals Announces Reverse Stock Split
-
Acorda CEO Dr. Ron Cohen Takes Huge Compensation Cut, Despite Boffo Year for Company - cbl
-
Regeneron Shares Surge 13% on Q1 Growth Report - cbl
-
Hearst & Reynolds Journalism Institute Announce Winners of 2012 Student Media Design Competition
-
Can Keryx Succeed Without Partnership?
-
What Will Pfizer Do With Its Newly Acquired $12 Billion?
-
Keryx Pharmaceuticals Reborn As A Speculative Play After Positive Trial News
-
Oligomerix Completes $2 Million Series A Financing
-
Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
-
Iris Pharma and RxGen Announce Strategic Alliance
-
MagnaCare Announces Multi-Year Agreement with Stellaris Health Network
-
Vichy Laboratoires Wins Marie Claire Beauty Award
-
Synergy Pharmaceuticals Could Realize Billion Dollar Potential
-
Connecticut Children?s Medical Center and Connecticut Children?s Specialty Group Term with Anthem Blue Cross and Blue Shield
-
Pfizer Will Plummet On New Quigley Lawsuit Developments
-
Likely Approval Spurring Rise Of Forest Laboratories Shares
-
MagnaCare Enters Exclusive Partnership with CarePoint Healthcare
-
Forest Laboratories Announces Buyout of Bystolic Royalties from Janssen Pharmaceutica NV
-
Wayne Rothbaum's Quogue Capital Opens 8% Stake worth $25.7M in Infinity Pharmaceuticals - cbl